Intus Bio
Mark Driscoll is the Co-Founder and CSO of Intus Biosciences, where he and his team have developed a groundbreaking platform for bacterial community profiling with strain-level resolution. Prior to Intus Biosciences, Mark served as an International Product Manager at 454 Life Sciences, a Roche company, and as a Group Leader at Molecular Staging Inc. Mark holds a Ph.D. from the University of Rochester School of Medicine and Dentistry and a Bachelor of Science in Biology from the University at Buffalo.
This person is not in any teams
Intus Bio
Intus Bio is using its proprietary high-resolution, high-throughput assay and analysis technology to identify bacteria and deliver answers about the microbiome, with unprecedented detail, accuracy and scale. The company is powering groundbreaking research, discovery and services with clients and partners across the global pharmaceutical, diagnostic, and testing industries; is active in health, agricultural, and environmental fields; and continues to develop new and innovative partnerships, technologies, and applications.